SPPL2a INHIBITORS
AR135266A1Pending Publication Date: 2026-08-05INCYTE CORP
0 Cites 0 Cited by
Patent Information
- Application Number
- ARP20250100400
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-04-11
- Filing Date
- 2025-02-14
- Publication Date
- 2026-08-05
Need to check novelty before this filing date? Find Prior Art
No text content released.
Claims
A compound characterized in that it is of formula (1) or a pharmaceutically acceptable salt or stereoisomer thereof. A pharmaceutical composition characterized in that it comprises a therapeutically effective amount of a compound according to any one of claims 1 to 25, or a pharmaceutically acceptable salt or stereoisomer thereof, and one or more pharmaceutically acceptable carriers. A combination characterized in that it comprises a therapeutically effective amount of a compound according to any one of claims 1 to 25, or a pharmaceutically acceptable salt or stereoisomer thereof, and at least one other pharmacological substance.